Data timelines which jump out from this announcement.
Azer-cel: Allogeneic CAR T cell therapy
- A preliminary early data update is anticipated in the second half of 2024
VAXINIA MAST Trial
- Bile tract cancer expansion trial opened and is expected to enroll approximately 10 patients; preliminary early data is expected in the second half 2024
OnCARlytics (CF33-CD19)
- Preliminary early combination data are expected in the fourth quarter of 2024
B Cell Immunotherapy: PD1-Vaxx
- Preliminary early data are expected in 2025
Good luck to all holders brave enough to have invested patient capital.
- Forums
- ASX - By Stock
- IMU
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-23
-
- There are more pages in this discussion • 97 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.9¢ |
Change
0.003(5.36%) |
Mkt cap ! $417.2M |
Open | High | Low | Value | Volume |
5.6¢ | 6.0¢ | 5.6¢ | $772.0K | 13.20M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 1258023 | 5.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.9¢ | 135684 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 107699 | 0.059 |
14 | 1296245 | 0.058 |
14 | 1307867 | 0.057 |
16 | 1734607 | 0.056 |
28 | 4891174 | 0.055 |
Price($) | Vol. | No. |
---|---|---|
0.060 | 2001151 | 30 |
0.061 | 305852 | 6 |
0.062 | 410148 | 9 |
0.063 | 548246 | 4 |
0.064 | 437640 | 5 |
Last trade - 13.13pm 20/06/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Chairman
Nick Poll
Executive Chairman
Previous Video
Next Video
SPONSORED BY The Market Online